Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual Abstract • About • The 20 audio files ← aioLingua Chinese Online ← Chinese aioLingua PDF

Parkinson's Disease

Free Subscription 13.10.2025 1 Ann Neurol 1 Brain Res 2 Exp Neurol 2 J Neural Transm (Vienna) 10 Mov Disord 2 Neurochem Res 1 Neurology 1 Neuroscience 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Ann Neurol

1. DAFSARI HS, Deneubourg C, Singh K, Maroofian R, et al
   Mutations in the Key Autophagy Tethering Factor EPG5 Link Neurodevelopmental and Neurodegenerative Disorders Including Early-Onset Parkinsonism.
   Ann Neurol. 2025 Oct 6. doi: 10.1002/ana.78013.
   PubMed         Abstract available
   
   

   
   Brain Res

2. HAJARE S, Kulkarni YA
   Parkinson's disease and the gut-brain connection: unveiling pathways, mechanisms and promising therapies.
   Brain Res. 2025 Oct 4:149975. doi: 10.1016/j.brainres.2025.149975.
   PubMed         Abstract available
   
   

   
   Exp Neurol

3. VENKATESH S, Kinzonzi N, Galfano A, Shah A, et al
   Optimizing L-DOPA treatment through treadmill controlled exercise in a hemi-parkinsonian rat model.
   Exp Neurol. 2025 Oct 8:115497. doi: 10.1016/j.expneurol.2025.115497.
   PubMed         Abstract available
   
   
4. MOLLER M, Nieweler JA, Nikulin VV, van Riesen C, et al
   Network mechanisms in rapid-onset dystonia-parkinsonism.
   Exp Neurol. 2025;395:115491.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

5. CONRING AL, Ye L, Wegner F, Korner S, et al
   Polyneuropathy in Parkinson's disease and atypical Parkinsonian syndromes: clinical impact and risk factors.
   J Neural Transm (Vienna). 2025 Oct 9. doi: 10.1007/s00702-025-03032.
   PubMed         Abstract available
   
   
6. WARNECKE T, Odin P, Garcia-Ramos R, Lopez L, et al
   Effects of levodopa-entacapone-carbidopa intrajejunal infusion on non-motor symptoms of advanced Parkinson's disease-interim analysis of the ELEGANCE study.
   J Neural Transm (Vienna). 2025 Oct 6. doi: 10.1007/s00702-025-03033.
   PubMed         Abstract available
   
   

   
   Mov Disord

7. 
   2025 International Congress of Parkinson's Disease and Movement Disorders.
   Mov Disord. 2025;40 Suppl 1:S246-S270.
   PubMed        
   
   
8. 
   2025 International Congress of Parkinson's Disease and Movement Disorders.
   Mov Disord. 2025;40 Suppl 1:S61-S77.
   PubMed        
   
   
9. 
   2025 International Congress of Parkinson's Disease and Movement Disorders.
   Mov Disord. 2025;40 Suppl 1:S163-S228.
   PubMed        
   
   
10. 
    2025 International Congress of Parkinson's Disease and Movement Disorders.
    Mov Disord. 2025;40 Suppl 1:S271-S381.
    PubMed        
    
    
11. 
    2025 International Congress of Parkinson's Disease and Movement Disorders.
    Mov Disord. 2025;40 Suppl 1:S78-S162.
    PubMed        
    
    
12. 
    2025 International Congress of Parkinson's Disease and Movement Disorders.
    Mov Disord. 2025;40 Suppl 1:S382-S412.
    PubMed        
    
    
13. 
    2025 International Congress of Parkinson's Disease and Movement Disorders.
    Mov Disord. 2025;40 Suppl 1:S229-S245.
    PubMed        
    
    
14. 
    2025 International Congress of Parkinson's Disease and Movement Disorders.
    Mov Disord. 2025;40 Suppl 1:S413-S1072.
    PubMed        
    
    
15. 
    2025 International Congress of Parkinson's Disease and Movement Disorders.
    Mov Disord. 2025;40 Suppl 1:S1-S60.
    PubMed        
    
    
16. RICCIARDI L, Fanciulli A, Cucinotta FP, Ishihara B, et al
    Sympathetic Shift and Insular Alteration: Unravelling the Link Between Anxiety and Heart Rate Variability in Parkinson's Disease.
    Mov Disord. 2025 Oct 7. doi: 10.1002/mds.70069.
    PubMed         Abstract available
    
    

    
    Neurochem Res

17. PENSABENE D, Martella N, Scavo G, Bisesto E, et al
    p75NTR Modulation by LM11A-31 Counteracts Oxidative Stress and Cholesterol Dysmetabolism in a Rotenone-Induced Cell Model of Parkinson's Disease.
    Neurochem Res. 2025;50:315.
    PubMed         Abstract available
    
    
18. WALECHA V, Luthra PM
    The Mitochondrial-Astrocyte-Neuron Triad Hypothesis in Parkinson's Disease: A Toxic Feedback Loop of Metabolism, Aggregation, and Oxidative Stress.
    Neurochem Res. 2025;50:317.
    PubMed         Abstract available
    
    

    
    Neurology

19. ORSO B, Mattioli P, Fama F, Massa F, et al
    Uncovering Clinical and Functional Neuroimaging Characteristics of Overt Stage Phenotypes Within the alpha-Synucleinopathy Spectrum.
    Neurology. 2025;105:e214253.
    PubMed         Abstract available
    
    

    
    Neuroscience

20. CHAHRA C, Sawssen M, Anis H, Salma N, et al
    Randomized, placebo-controlled pilot study of Origanum majorana tea on oxidant/antioxidant stress biomarkers in Parkinson's idiopathic disease: a randomized controlled pilot Tunisian study.
    Neuroscience. 2025 Oct 4:S0306-4522(25)00977.
    PubMed         Abstract available
    
    

    
    PLoS One

21. RODRIGUEZ-MARTIN D, Catala A, Cabestany J
    Improving Parkinson's disease management through wearable technology: A cost-benefit perspective.
    PLoS One. 2025;20:e0334413.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.